BLSCX
Price
$11.15
Change
+$0.05 (+0.45%)
Updated
Sep 17 closing price
Net Assets
53.48M
RNWAX
Price
$90.32
Change
+$0.03 (+0.03%)
Updated
Sep 17 closing price
Net Assets
74.08B
Interact to see
Advertisement

BLSCX vs RNWAX

Header iconBLSCX vs RNWAX Comparison
Open Charts BLSCX vs RNWAXBanner chart's image
BlackRock Advantage Emerging Mkts Inv C
Price$11.15
Change+$0.05 (+0.45%)
VolumeN/A
Net Assets53.48M
American Funds New World R1
Price$90.32
Change+$0.03 (+0.03%)
VolumeN/A
Net Assets74.08B
BLSCX vs RNWAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BLSCX vs. RNWAX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLSCX is a Hold and RNWAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 74.1B vs. BLSCX (53.5M). BLSCX pays higher dividends than RNWAX: BLSCX (3.79) vs RNWAX (0.00). BLSCX was incepted earlier than RNWAX: BLSCX (14 years) vs RNWAX (23 years). BLSCX (2.59) is less costly to investors than RNWAX (1.66). BLSCX is a more actively managed with annual turnover of: 274.00 vs. RNWAX (37.00). RNWAX has a lower initial minimum investment than BLSCX: RNWAX (250) vs BLSCX (1000). BLSCX annual gain was more profitable for investors over the last year : 22.51 vs. RNWAX (15.82). RNWAX return over 5 years is better than : 26.96 vs. BLSCX (20.95).
BLSCXRNWAXBLSCX / RNWAX
Total Expense Ratio1.911.66115%
Annual Report Gross Expense Ratio2.591.66156%
Fund Existence14 years23 years-
Gain YTD23.95022.667106%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets53.5M74.1B0%
Annual Yield % from dividends3.790.00-
Returns for 1 year22.5115.82142%
Returns for 3 years44.5946.8395%
Returns for 5 years20.9526.9678%
Returns for 10 years29.7389.5833%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNTH38.841.37
+3.66%
Dianthus Therapeutics
FERAU10.50N/A
N/A
Fifth Era Acquisition Corp I
SIMA10.46N/A
N/A
SIM Acquisition Corp I
STVN26.93-0.30
-1.10%
Stevanato Group SpA
CPIX3.23-0.13
-3.87%
Cumberland Pharmaceuticals